ShangBay Capital LLC β Full Portfolio
67 tracked investments Β· listed companies and verified rows first
Ceribell develops a point-of-care EEG system that uses AI to detect seizure activity, including status epilepticus, in patients.
AI & Machine LearningHealthtechMedical DevicesSunnyvale, US
Joseph Taylor(Director)Scott Blumberg(Executive Officer)Lucian Iancovici(Director)Raymond Woo(Executive Officer)Josef Parvizi(Director)David Stoffel(Executive Officer)
Luminopia develops software-based therapeutics for neuro-visual disorders that stem from deficiencies in the brain rather than the eyes, generating therapeutic visual stimuli delivered through a virtual reality headset.
BiotechDigital HealthMedical DevicesAspen, US
DEAN A. TRAVERS(Executive Officer, Director)SCOTT XIAO(Executive Officer, Director)ALEXANDER WENDLAND(Executive Officer, Director)Scott Xiao(Co-Founder & CEO)Dean Travers(Co-Founder)Brion Raymond(CBO)
Petal is developing an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted diseased tissue without incisions, heat, or trauma.
BiotechDeep TechHealthtechMedical DevicesRedwood City, US
Prashant Chopra(Executive Officer, Director, Promoter)Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Rony Abovitz(Co-founding Advisor)
BoardFrederic Moll(Director)
Petal Surgical develops an incisionless surgery platform using Millisecond Pulse Histotripsy, a form of focused therapeutic ultrasound that breaks down targeted tissue via "Acoustic Liquefaction" without cutting, heat, or trauma.
Deep TechHealthtechMedical Devices
Prash Chopra(Founding CEO & Director)Bowen Jiang(Co-founder)Nicholas Theodore(Co-founder & Director)Frederic H. Moll(Director)Rony Abovitz(Co-founding Advisor)
Abcuro is a clinical-stage biopharmaceutical company developing ulviprubart, a monoclonal antibody that selectively depletes highly cytotoxic T cells by targeting the KLRG1 receptor.
BiotechHealthtechNewton, US
John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Alex Martin(Chief Executive Officer)
BiotechMenlo Park, US
Xin Guo(Director)Dongliang Ge(Executive Officer, Director)Bo Zhang(Executive Officer, Director)
BoardWilliam Dai(Director)
BiotechCampbell, US
Henry Chen(Director)Claudio Argento(Director)Mariam Maghribi(Executive Officer, Director)Amr Salahieh(Director)Casey Gordon(Director)
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Thomas Shehab, MD(Director)Kevin Wasserstein(Director)
Berkeley Lights (now Bruker Cellular Analysis) develops the Beacon optofluidic system for single-cell functional analysis, enabling researchers to profile live single cells to discover therapeutic antibodies, interrogate T cells, identify cell therapies, and accelerate cell line development.
BiotechDeep TechHardwareEmeryville, US
BiotechCharlottesville, US
Kevin S Eisenfrats(Executive Officer, Director, Promoter)Tom Thorpe(Director)Michael King(Director)
BoardIris Van Alderwerelt van Rosenburgh(Director)Gurdane Bhutani(Director)Martin J Emerson(Director)
Fremont, US
Erik Engelson(Director)Skott Greenhalgh(Director)
BoardMichael Wallace(Executive Officer, Director)
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers.
FemTechHealthtechMedical Devices
Fluid Biomed develops the ReSolv stent, a hybrid polymer-metal, self-expanding flow-diverting stent designed to treat brain aneurysms and reduce the risk of rupture and stroke.
BiotechHealthtechMedical Devices
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases.
AI & Machine LearningBiotechHealthtechSouth San Francisco, US
Kari Nadeau(Scientific Co-Founder)
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)Guo-Liang Yu(Director)Liqun Luo(Director)
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation.
HealthtechMedical DevicesPlymouth, US
Ramji Iyer(Executive Officer, Director)
BoardJenny H. Barba(Director)Todd Mortier(Director)Colin Morrison(Director)
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inSteve Tablak(Director)Justin Butler(Director)Tuff Yen(Director)John R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)
Magnetic Insight develops magnetic particle imaging technology that uses non-radioactive tracers as an alternative to conventional radioactive tracers used in nuclear medicine scans.
Deep TechHealthtechMedical Devices
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)Brian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions.
Deep TechHealthtechMedical DevicesCalifornia, US
JEFF PETERS(Director)LU GANG(Director)DAVE FERRERA(Director)JIANLU MA(Executive Officer, Director)
BoardWILLIAM DAI(Director)
California-based surgical robotics company focused on endoluminal robotics.
HealthtechCambridge, US
James A. Stefater(Executive Officer)Michael Singer(Director)Richel Liu(Director)Thomas P. Stryjewski(Director)Sameer Sabir(Director)Carl Berke(Director)
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach.
BiotechHealthtechMedical DevicesValencia, US
Developing SKY-0515 for Huntington's Disease; running the global pivotal FALCON-HD clinical trial.
Develops a non-invasive solution using alternating magnetic field technology to treat infected metallic implants by eradicating biofilms.
College Station, US
James Y Lancaster(Executive Officer, Director)John Hodock(Director)Robert Calvin Goforth(Director)
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment.
BiotechHealthtechMedical DevicesChapel Hill, US
William N. Starling(Director)Daniel Estay(Executive Officer, Director)
Irvine, US
Ken Wang(Executive Officer, Director)Dongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)Jing Zhang(Director)Bo Li(Director)Xiansheng Duan(Director)
BiotechMenlo Park, US
Dongxu Sun(Executive Officer, Director)Ke Hong(Executive Officer, Director)
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods.
HealthtechMedical DevicesLos Gatos, US
Erik van der Burg(Executive Officer, Director)
BoardMichael Wallace(Director)Darshana Zaveri(Director)Shant Vartanian(Director)
Window Therapeutics develops cancer therapeutics using its proprietary Bottle-brush-Analogue-Macromonomer (BAM) technology, which aims to widen the therapeutic window of drugs by increasing their activity against cancer cells while reducing systemic toxicity to healthy tissue.
BiotechDeep TechHealthtechBoston, US
James Lu(Director)Jeremiah Johnson(Director)Lusong Luo(Director)Kenneth Anderson(Director)Chih-Kao Hu(Executive Officer, Director)Kenneth C. Anderson(Professor, Researcher and Clinician, Harvard Medical School & DFCI)
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(Founder/CTO)inNick Damiano(Executive Officer, Director)John Beck(Executive Officer)
BoardBryan Kim(Director)Robert Weisskoff(Director)Blayne Roeder(Director)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.